Edick Paul R Insider Trades

Insider Trading History

Track insider trading activity for Edick Paul R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director
Holding Value $20.3k 35,200 shares
Last Trade
Oct 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 35,200 shares
$3.90
$0.58
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $23.3M 3,788,064 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 500,000 shares
$2.46
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $14.1M 2,288,064 shares
Last Trade
Aug 09, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.8k 10,000 shares
$2.38
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $14M 2,278,064 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$930k 750,000 shares
$1.24
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $9.4M 1,528,064 shares
Last Trade
Dec 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$29k 20,000 shares
$1.45
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $9.27M 1,508,064 shares
Last Trade
May 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$140k 100,000 shares
$1.40
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $8.66M 1,408,064 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.69M 600,000 shares
$2.81
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $206k 33,430 shares
Last Trade
Nov 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$45.6k 20,000 shares
$2.28
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $4.97M 808,064 shares
Last Trade
Nov 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$416k 200,000 shares
$2.08
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $4.11M 668,065 shares
Last Trade
Oct 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.88M 2,057,633 shares
$2.37
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
Chief Executive Officer
Holding Value $2.53M 410,833 shares
Last Trade
Oct 05, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.32M 978,735 shares
$2.37
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $3.91M 636,134 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.18M 625,000 shares
$5.08
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $2.53M 411,134 shares
Last Trade
Dec 09, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40.6k 10,000 shares
$4.06
$6.15
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $19.4k 15,000 shares
Last Trade
Jun 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.1k 15,000 shares
$3.74
$1.29
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $2.47M 401,134 shares
Last Trade
May 08, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$99k 33,000 shares
$3.00
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $1.13M 183,134 shares
Last Trade
Feb 14, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$83k 20,000 shares
$4.15
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $2.26M 368,134 shares
Last Trade
Jan 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 185,000 shares
$6.37
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $1M 163,134 shares
Last Trade
Jan 31, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$62.4k 9,801 shares
$6.37
$6.15
Xeris Biopharma Holdings
Xeris Biopharma Holdings XERS
See Remarks
Holding Value $1.06M 172,935 shares
Last Trade
Nov 25, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$153k 17,935 shares
$8.55
$6.15
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
Director
Holding Value $942 31,390 shares
Last Trade
May 24, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$578k 6,154 shares
$93.90
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up